Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions

Research output: Book/ReportOther report

Author(s)

Department/unit(s)

Publication details

DatePublished - Apr 2012
Number of pages40
PublisherCentre for Health Economics, University of York
Place of PublicationYork UK
Volume77
Original languageEnglish

Publication series

NameCHE Research Paper
PublisherCentre for Health Economics, University of York
No.77

Abstract

Until recently, purchasers’ options regarding whether to pay for the use of technologies have been binary in nature: a treatment is covered or not covered. However, policies have emerged which expand the options - for example, linking coverage to evidence development, an option increasingly used for new treatments with limited/uncertain evidence. There has been little effort to reconcile the features of technologies with the available options in a way that reflects purchasers’ ranges of authority

    Research areas

  • health technology assessment, cost effectiveness, comparative effectiveness, only in research, coverage with evidence development, patient access scheme

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations